Archives
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
August 2005
July 2005
June 2005
May 2005
April 2005
March 2005
February 2005
January 2005
December 2004
November 2004
October 2004
September 2004
August 2004
July 2004
June 2004
May 2004
|
PETA Notifies EPA That Greenpeace, Center for Food Safety, and Others Took Big Bucks From Drugmaker
PETA
April 16, 2009
By Samantha Dozier
Washington -- PETA has submitted comments to the U.S. Environmental Protection Agency (EPA) asking it to turn down a petition from the International Center for Technology Assessment (ICTA) that calls for the regulation of nanosilver. Although nanosilver has been available over the counter for years to treat general infections, the petition urges the EPA to treat the substance as a new pesticide--a move that would require deadly and unreliable tests to be conducted on thousands of animals. In its comments, PETA points out that, according to news reports, pharmaceutical giant Merck has given more than $1.75 million to various signatories to the petition. If nanosilver were to be regulated as a pesticide, Merck's prescription antibiotics would have a competitive advantage. According to these reports, some of the signatories to the ICTA petition that received money from Merck include ICTA itself ($247,500), the Center for Food Safety ($1,305,000), the Institute for Agriculture and Trade Policy ($490,000), the Consumers Union of the United States ($90,000), Greenpeace ($80,000), and Friends of the Earth ($45,000). A former Food and Drug Administration commissioner admitted that 92 percent of the drugs that pass animal tests fail clinical trials in humans. To prevent similar failures in the emerging field of nanotechnology as well as the deaths of countless animals, PETA is calling on the EPA to use human-relevant, in vitro, nanotechnology-specific methods to test nanosilver instead of cumbersome, antiquated, animal-based methods. "The interest in regulating nanosilver after all these years comes from a number of groups that have accepted funds from Merck," says PETA Director of Regulatory Testing Jessica Sandler. "We're calling on the EPA to toss this petition into the paper shredder and not allow it to cause the agonizing deaths of thousands of animals."
NOTICE: In
accordance with Title 17 U.S.C. Section 107, this material is
distributed without profit to those who have expressed a prior
interest in receiving this information for research and
educational purposes.
|